The effect of midazolam premedication on patient satisfaction during fiberoptic bronchoscopy under patient-controlled

Won Kyoung Kwon1, Eun Su Choi1, Ji Young Kim1

  • 1Department of Anesthesiology and Pain Medicine, College of Medicine, Konkuk University, Seoul, Korea.

Abstract

Insights

Adding midazolam to patient-controlled sedation (PCS) for fiberoptic bronchoscopy improved patient satisfaction and amnesia. This combination offers a more comfortable experience for patients undergoing the procedure.

Area of Science:

  • Anesthesiology
  • Pulmonology
  • Pharmacology

Background:

  • Patient-controlled sedation (PCS) using propofol is established for managing discomfort during fiberoptic bronchoscopy.
  • Evaluating adjuncts to PCS can optimize procedural sedation and patient experience.

Purpose of the Study:

  • To assess the efficacy and impact of adding midazolam to propofol-based PCS for fiberoptic bronchoscopy.

Main Methods:

  • A randomized controlled trial involving 155 patients undergoing diagnostic bronchoscopy.
  • Patients received either midazolam premedication or propofol/alfentanil PCS, with both groups receiving standardized PCS infusions.
  • Outcomes measured included vital signs, procedural satisfaction (patient and pulmonologist), and patient amnesia.

Main Results:

  • No significant differences in vital signs (SpO2, blood pressure, heart rate) were observed between groups.
  • Patients receiving midazolam (Group M) reported higher satisfaction and better amnesia compared to the PCS-only group (Group P).
  • Group P required more supplemental bolus injections of sedation, indicating potentially less effective sedation titration.

Conclusions:

  • Midazolam, when used as premedication with propofol-based PCS, enhances patient satisfaction and amnesia during fiberoptic bronchoscopy.
  • PCS remains an effective sedation method, but adjuncts like midazolam can further improve patient-centered outcomes.

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
269
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
263
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
235
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304